David F. Stern, PhD
Professor of Pathology; Associate Director, Shared Resources, Yale Cancer Center; Leader, Signal Transduction Research Program, Yale Cancer Center
Departments & Organizations
Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology
Cancer Prevention and Control Center
Pathology
Signal Transduction
Research Interests
Cancer Biology: signal transduction by HER2/ErbB2 and other EGF family receptor tyrosine kinases; EGF family receptors in breast cancer and mammary development; DNA damage checkpoint signaling; Functional and genetic analysis of cancer; Melanoma more...
Education
- B.S., Massachusetts Institute of Technology, 06/1976
- Ph.D., University of California, San Diego, 1983
Selected Publications
- Gilmore-Hebert, M., Ramabhadran, R, and DF. Stern. 2010. Interactions of ErbB4 and Kap1 connect growth factor and DNA damage response pathways. Mol Cancer Res EPub ahead of print.
- Agarwal,S, Zerillo,., Kolmakova, J., Christensen, JG, Harris, LN, Rimm, DL, DiGiovanna, MP, David F. Stern (2009) Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/HER2 inhibitor in non-small-cell lung cancer cells, British J. Cancer, 100:941-949.
- David F. Stern 2009. BRCTing Up is Hard to Do, Molecular Cell, 33, 137-138.
